A collaborative study with Harvard Medical School
A Transformative Wound Management Approach with BMG™ Technology – A National 50-Patient Case Study Series (Preliminary Report)
Publication Details:
Tickle, J. and Pramod, S., 2023. EP 373 A TRANSFORMATIVE WOUND MANAGEMENT APPROACH WITH BMG TECHNOLOGY--FINAL REPORT OF A NATIONAL 50 PATIENT CASE STUDY SERIES. Journal of Wound Management, 24(2).
Wound Details
Category 3 sacral pressure ulcers that had been static, non-healing for six months. The study involves 50 adult patients across 10 clinical settings
Key Findings and Data:
MaxioCel® demonstrated:
53-year-old male with Category 3 sacral pressure ulcers (static for 6 months).
- 08.09.22 (Initial):
- Wound 1: L15 cm × W7 cm × D1.5 cm, 10% slough, 5% necrosis, moderate-high exudate.
- Wound 2: L7 cm × W3.5 cm × D0.5 cm, 5% slough, moderate-high exudate.
- 11.10.22 (Week 4):
- Wound 1: L6 cm × W3.5 cm × D0.5 cm, 100% granulation, healthy periwound skin, low exudate.
Wound 2: L6 cm × W3.5 cm × D0.5 cm, 100% granulation, no slough or undermining, clear signs of healing.
Key Insights
- MaxioCel® facilitates faster healing by managing exudate, reducing infection risk, and promoting tissue regeneration.
- Study findings support the use of Maxiocel across diverse wound types, validating its effectiveness in both acute and chronic wound care settings.
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
